Chenguang Biotech Group (300138) — Financial Flexibility Index
Chenguang Biotech Group (300138) has a Financial Flexibility Index of 0.12x as of September 2025. Free cash flow of CN¥562.60 Million (operating CF CN¥524.96 Million minus capex CN¥37.63 Million) represents 0% of total liabilities (CN¥4.57 Billion). Check 300138 capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Chenguang Biotech Group Financial Flexibility Index (2007–2024)
Historical Financial Flexibility Index trend for Chenguang Biotech Group across 18 annual periods. For the full cash flow conversion analysis, see Chenguang Biotech Group operating cash flow efficiency.
Annual Financial Flexibility Index for Chenguang Biotech Group (2007–2024)
Year-by-year free cash flow to debt coverage for Chenguang Biotech Group. Explore debt repayment capacity of Chenguang Biotech Group to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.01x | CN¥-73.28 Million | CN¥-222.81 Million | CN¥5.87 Billion | ▲ +80.6% |
| 2023 | -0.06x | CN¥-321.71 Million | CN¥-510.91 Million | CN¥5.01 Billion | ▼ -126.2% |
| 2022 | 0.25x | CN¥910.84 Million | CN¥734.81 Million | CN¥3.71 Billion | ▲ +125.9% |
| 2021 | 0.11x | CN¥344.72 Million | CN¥63.90 Million | CN¥3.17 Billion | ▼ -70.8% |
| 2020 | 0.37x | CN¥966.29 Million | CN¥529.41 Million | CN¥2.59 Billion | ▲ +326.7% |
| 2019 | 0.09x | CN¥241.38 Million | CN¥-24.35 Million | CN¥2.77 Billion | ▲ +69.3% |
| 2018 | 0.05x | CN¥83.35 Million | CN¥-56.18 Million | CN¥1.62 Billion | ▲ +454.2% |
| 2017 | -0.01x | CN¥-18.18 Million | CN¥-145.95 Million | CN¥1.25 Billion | ▲ +93.8% |
| 2016 | -0.23x | CN¥-226.80 Million | CN¥-321.62 Million | CN¥967.46 Million | ▼ -1496.6% |
| 2015 | 0.02x | CN¥9.47 Million | CN¥-64.66 Million | CN¥564.12 Million | ▼ -97.3% |
| 2014 | 0.62x | CN¥309.58 Million | CN¥272.96 Million | CN¥499.69 Million | ▲ +889.6% |
| 2013 | 0.06x | CN¥40.15 Million | CN¥-36.47 Million | CN¥641.26 Million | ▲ +470.7% |
| 2012 | -0.02x | CN¥-7.56 Million | CN¥-142.11 Million | CN¥447.73 Million | ▼ -100.9% |
| 2011 | 1.79x | CN¥263.90 Million | CN¥82.18 Million | CN¥147.16 Million | ▲ +516.1% |
| 2010 | -0.43x | CN¥-93.05 Million | CN¥-190.51 Million | CN¥215.92 Million | ▼ -188.0% |
| 2009 | 0.49x | CN¥94.13 Million | CN¥27.23 Million | CN¥192.17 Million | ▲ +231.1% |
| 2008 | 0.15x | CN¥35.11 Million | CN¥9.06 Million | CN¥237.31 Million | ▲ +228.9% |
| 2007 | -0.11x | CN¥-9.81 Million | CN¥-23.02 Million | CN¥85.49 Million | — |